FDA.reportPublic FDA data

Repatha 140 MG in 1 ML Auto-Injector

RxCUI
1665900
RxNorm name
Repatha 140 MG in 1 ML Auto-Injector
Display name
Repatha 140 MG in 1 ML Auto-Injector
Full name
Repatha 140 MG in 1 ML Auto-Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125522Repathaevolocumab351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cd61e902-166d-4aa6-9f3c-a18c1008d07eRepatha 140 MG in 1 ML Auto-Injector [PSN] · 1 ML evolocumab 140 MG/ML Auto-Injector [Repatha] [SBD] · 1 ML Repatha 140 MG/ML Auto-Injector [SY] · 1 ML Repatha SureClick 140 MG/ML Auto-Injector [SY]427These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 201520260122